Literature DB >> 16638843

Tumor necrosis factor-related apoptosis-inducing ligand pathway and its therapeutic implications.

Elisabeth G E de Vries1, Jourik A Gietema, Steven de Jong.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16638843     DOI： 10.1158/1078-0432.CCR-06-0352

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  13 in total

1.  A genetically encoded multifunctional TRAIL trimer facilitates cell-specific targeting and tumor cell killing.

Authors:  Dirk Spitzer; Jonathan E McDunn; Stacey Plambeck-Suess; Peter S Goedegebuure; Richard S Hotchkiss; William G Hawkins
Journal:  Mol Cancer Ther       Date:  2010-06-22       Impact factor: 6.261

Review 2.  Receptor Occupancy Imaging Studies in Oncology Drug Development.

Authors:  Ingrid J G Burvenich; Sagun Parakh; Adam C Parslow; Sze Ting Lee; Hui K Gan; Andrew M Scott
Journal:  AAPS J       Date:  2018-03-08       Impact factor: 4.009

3.  Phase I trial of weekly tigatuzumab, an agonistic humanized monoclonal antibody targeting death receptor 5 (DR5).

Authors:  Andres Forero-Torres; Jatin Shah; Tina Wood; James Posey; Ronda Carlisle; Catherine Copigneaux; Feng Roger Luo; Slawomir Wojtowicz-Praga; Ivor Percent; Mansoor Saleh
Journal:  Cancer Biother Radiopharm       Date:  2010-02       Impact factor: 3.099

Review 4.  Autophagy modulation for cancer therapy.

Authors:  Zhineng J Yang; Cheng E Chee; Shengbing Huang; Frank Sinicrope
Journal:  Cancer Biol Ther       Date:  2011-01-15       Impact factor: 4.742

5.  Phase I Imaging and Pharmacodynamic Trial of CS-1008 in Patients With Metastatic Colorectal Cancer.

Authors:  Marika Ciprotti; Niall C Tebbutt; Fook-Thean Lee; Sze-Ting Lee; Hui K Gan; David C McKee; Graeme J O'Keefe; Sylvia J Gong; Geoffrey Chong; Wendie Hopkins; Bridget Chappell; Fiona E Scott; Martin W Brechbiel; Archie N Tse; Mendel Jansen; Manabu Matsumura; Masakatsu Kotsuma; Rira Watanabe; Ralph Venhaus; Robert A Beckman; Jonathan Greenberg; Andrew M Scott
Journal:  J Clin Oncol       Date:  2015-06-29       Impact factor: 44.544

6.  The tumour necrosis factor/TNF receptor superfamily: therapeutic targets in autoimmune diseases.

Authors:  D S Vinay; B S Kwon
Journal:  Clin Exp Immunol       Date:  2011-03-14       Impact factor: 4.330

7.  Quercetin promotes degradation of survivin and thereby enhances death-receptor-mediated apoptosis in glioma cells.

Authors:  Markus D Siegelin; David E Reuss; Antje Habel; Abdelhaq Rami; Andreas von Deimling
Journal:  Neuro Oncol       Date:  2008-10-29       Impact factor: 12.300

Review 8.  Emerging roles of lactic acid bacteria in protection against colorectal cancer.

Authors:  Li Zhong; Xufei Zhang; Mihai Covasa
Journal:  World J Gastroenterol       Date:  2014-06-28       Impact factor: 5.742

9.  Triptolide sensitizes pancreatic cancer cells to TRAIL-induced activation of the death receptor pathway.

Authors:  Zhiyu Chen; Veena Sangwan; Sulagna Banerjee; Rohit Chugh; Vikas Dudeja; Selwyn M Vickers; Ashok K Saluja
Journal:  Cancer Lett       Date:  2014-03-21       Impact factor: 8.679

10.  A bioengineered organotypic prostate model for the study of tumor microenvironment-induced immune cell activation.

Authors:  Sheena C Kerr; Molly M Morgan; Amani A Gillette; Megan K Livingston; Karina M Lugo-Cintron; Peter F Favreau; Logan Florek; Brian P Johnson; Joshua M Lang; Melissa C Skala; David J Beebe
Journal:  Integr Biol (Camb)       Date:  2020-10-16       Impact factor: 3.177
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.